title: Technology: Investment suggests RNAi is on the up.
authors.affiliation: Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
authors.forename: John
authors.initials: J
authors.lastname: Maraganore
mesh_terms: D001709:Biotechnology / Q000379:methods* / Q000639:trends*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D034622:RNA Interference